Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
mario.venditti@uniroma1.it
Mario Venditti
Professore Ordinario
Struttura:
DIPARTIMENTO DI SANITA' PUBBLICA E MALATTIE INFETTIVE
E-mail:
mario.venditti@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
High incidence of Candidemia in critically Ill COVID-19 patients supported by veno-venous extracorporeal membrane oxygenation. A retrospective study
JOURNAL OF FUNGI
2023
Toll-Like Receptor 4-Dependent Platelet-Related Thrombosis in SARS-CoV-2 Infection
CIRCULATION RESEARCH
2023
Risk factors and effect on mortality of superinfections in a newly established COVID-19 respiratory sub-intensive care unit at University hospital in Rome
BMC PULMONARY MEDICINE
2023
Association between PaO2/FiO2 ratio and thrombotic events in COVID-19 patients
INTERNAL AND EMERGENCY MEDICINE
2023
Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies: results from the HM-COV 2.0 study
CLINICAL AND EXPERIMENTAL MEDICINE
2023
Chronic Suppressive Antibiotic Treatment for Staphylococcal Bone and Joint Implant–Related Infections
ANTIBIOTICS
2023
Clinical characteristics and outcome of ceftazidime/avibactam-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae infections. A retrospective, observational, 2-center clinical study
OPEN FORUM INFECTIOUS DISEASES
2023
Reduced Reliability of Procalcitonin (PCT) as a Biomarker of Bacterial Superinfection: Concerns about PCT-Driven Antibiotic Stewardship in Critically Ill COVID-19 Patients—Results from a Retrospective Observational Study in Intensive Care Units
JOURNAL OF CLINICAL MEDICINE
2023
Risk factors for carbapenem-resistant Acinetobacter baumannii (crab) bloodstream infections and related mortality in critically ill patients with (crab) colonization
JAC-ANTIMICROBIAL RESISTANCE
2023
Acute bacterial skin and skin structure infections in pediatric patients: potential role of dalbavancin
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
2023
Ceftazidime/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: Analysis of cases and evaluation of in vitro activity of fosfomycin-containing combinations
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE
2023
New Antimicrobials and New Therapy Strategies for Endocarditis: Weapons That Should Be Defended
JOURNAL OF CLINICAL MEDICINE
2023
Did the updated Duke criteria missed Erysipelothrix rhusiopathiae from the list of typical microorganisms causing infective endocarditis?
LE INFEZIONI IN MEDICINA
2023
Invasive Candida infection: epidemiology, clinical and therapeutic aspects of an evolving disease and the role of rezafungin
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
2023
First case of persistent Stenotrophomonas maltophilia bacteraemia due to septic thrombosis successfully treated with a cefiderocol-containing regimen
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE
2023
Interplay between Klebsiella pneumoniae producing KPC-31 and KPC-3 under treatment with high dosage meropenem. A case report
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
2022
High Activity of N-Acetylcysteine in Combination with Beta-Lactams against Carbapenem-Resistant Klebsiella pneumoniae and Acinetobacter baumannii
ANTIBIOTICS
2022
Convalescent plasma for haematological patients with SARS-CoV-2 pneumonia and severe depletion of B-cell lymphocytes following anti-CD20 therapy: a single-centre experience and review of the literature
NEW MICROBIOLOGICA
2022
Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections in Patients With Liver Cirrhosis
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY
2022
THE ADA (AGE-D-DIMER-ALBUMIN) SCORE TO PREDICT THROMBOSIS IN SARS-CoV-2
THROMBOSIS AND HAEMOSTASIS
2022
1
2
3
4
5
6
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma